NASDAQ · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · SMALL CAP
Synergy CHC Corp. SNYR
11 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$30.4M
▼ 12.8% vs FY2024
EPS · FY25
$-1.27
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-40.6%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 30.4M
Revenue, FY2025 · full 11-year series below
Revenue
Net income
The company lost 41 cents on every revenue dollar this year.
Per share
USD -1.27
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin-27.8%
Net margin-40.6%
Return on assets-93.1%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+8.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+44.7%
Change, 10 years—
The share count grew 45% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 10.2M
total assets, end of FY2025
Total assetsUSD 10.2M
EquityUSD -23.1M
CashUSD 2.6M
Gross debtUSD 25.1M
Net debtUSD 22.4M
Current ratio1.22×
Net debt stands at -97% of equity.
History
11 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2019
2018
2017
2016
2015
2014
2013
2012
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
Operating income $B
−0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
·
·
EBITDA $B
·
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
·
·
Income tax $B
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
Net income $B
−0.0
0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−1.27
0.28
0.86
−0.10
−0.07
0.01
−0.01
−0.11
−0.01
0.00
0.00
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
−16
·
·
·
ROE %
·
·
·
·
−91.9
6.0
−12.7
−284.7
·
·
·
Shares out B
0.01
0.00
0.01
0.09
0.09
0.09
0.09
0.08
0.06
0.18
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
40 of 40
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed